[
    [
        {
            "time": "2023-05-12",
            "original_text": "安图生物：2037.58万股限售股5月12日解禁 解禁",
            "features": {
                "keywords": [
                    "安图生物",
                    "限售股",
                    "解禁"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "安图生物：2037.58万股限售股5月12日解禁 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-30",
            "original_text": "晚间公告丨4月30日这些公告有看头",
            "features": {
                "keywords": [
                    "晚间公告",
                    "4月30日"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "晚间公告丨4月30日这些公告有看头",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "为保持IVD技术领先性 安图生物(603658.SH)控股股东拟投设生物医药产业投资基金",
            "features": {
                "keywords": [
                    "安图生物",
                    "IVD技术",
                    "生物医药产业投资基金"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "为保持IVD技术领先性 安图生物(603658.SH)控股股东拟投设生物医药产业投资基金",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "安图生物(603658.SH)：2037.576万股限售股5月12日解禁 解禁",
            "features": {
                "keywords": [
                    "安图生物",
                    "限售股",
                    "解禁"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "安图生物(603658.SH)：2037.576万股限售股5月12日解禁 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "安图生物(603658.SH)：控股股东拟设立生物医药产业投资基金",
            "features": {
                "keywords": [
                    "安图生物",
                    "控股股东",
                    "生物医药产业投资基金"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物(603658.SH)：控股股东拟设立生物医药产业投资基金",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "安图生物：同意控股股东设立产业基金投资IVD项目",
            "features": {
                "keywords": [
                    "安图生物",
                    "控股股东",
                    "产业基金",
                    "IVD项目"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物：同意控股股东设立产业基金投资IVD项目",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "安图生物(603658.SH)：2037.58万股限售股于5月12日上市流通 解禁",
            "features": {
                "keywords": [
                    "安图生物",
                    "限售股",
                    "解禁"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "安图生物(603658.SH)：2037.58万股限售股于5月12日上市流通 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "医药“小阳春”行情渐入佳境 医药龙头股票有哪些？",
            "features": {
                "keywords": [
                    "医药",
                    "小阳春",
                    "龙头股票"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药“小阳春”行情渐入佳境 医药龙头股票有哪些？",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-03-31",
            "original_text": "明星私募一季度调仓：冯柳现身25家公司持仓超300亿 高瓴礼仁新进安图生物、伊利",
            "features": {
                "keywords": [
                    "明星私募",
                    "冯柳",
                    "高瓴礼仁",
                    "安图生物",
                    "伊利"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "明星私募一季度调仓：冯柳现身25家公司持仓超300亿 高瓴礼仁新进安图生物、伊利",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "一周机构评级：26股获扎堆推荐 18股看涨空间超20%",
            "features": {
                "keywords": [
                    "机构评级",
                    "扎堆推荐",
                    "看涨空间"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一周机构评级：26股获扎堆推荐 18股看涨空间超20%",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "顶流基金最新动向曝光：张坤看多苏泊尔 高瓴旗下私募新进伊利股份、华大基因、安图生物",
            "features": {
                "keywords": [
                    "顶流基金",
                    "张坤",
                    "高瓴",
                    "安图生物",
                    "伊利股份",
                    "华大基因"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "消费",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "顶流基金最新动向曝光：张坤看多苏泊尔 高瓴旗下私募新进伊利股份、华大基因、安图生物",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "年报收官 河南A股上市公司去年共营收6607亿元 其中1家过千亿",
            "features": {
                "keywords": [
                    "年报",
                    "河南A股",
                    "营收",
                    "6607亿元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "年报收官 河南A股上市公司去年共营收6607亿元 其中1家过千亿",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]